z-logo
open-access-imgOpen Access
Method for Determining the Radiochemical Purity of Radiopharmaceuticals Based on Iodine-125, Iodine-131 and Samarium-153-oxabifor
Author(s) -
Khajievlaziz Ozodovich,
Sadikovilhom Ismoilovich,
Abdukayumovayubkhan Melisovich,
Rikhsievabror Zikirovich
Publication year - 2021
Publication title -
international journal of emerging trends in engineering research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.218
H-Index - 14
ISSN - 2347-3983
DOI - 10.30534/ijeter/2021/11932021
Subject(s) - radiochemistry , iodine , radionuclide , chemistry , iodide , samarium , sodium iodide , irradiation , inorganic chemistry , nuclear physics , physics , organic chemistry
iopharmaceuticals used in medicine for diagnostics, treatment, and anesthesia in various diseases. Radionuclide 125I was obtained by irradiation with neutrons of the enriched isotope 124Хе in a nuclear reactor. 131I was isolated from irradiated samples of TeO2 enriched in 130Те, and radionuclide 153Sm was obtained by irradiation of samples 152Sm2O3 in a nuclear reactor. The radiochemical purity of sodium iodide preparations labeled with 125I or 131I radionuclides was determined by the electrophoretic method, and the samarium-153-oxabifor preparation was determined by ascending paper chromatography. To determine the distribution of the activity of 125I, 131I, and 153Sm-oxabiphor by electrophoregrams and chromatograms, a γ-radiometric device Ludlum-2200 was used, which makes it possible to determine the radiochemical purity at the level of 99.9%.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom